home / stock / lxrx / lxrx articles

LXRX Articles, Lexicon Pharmaceuticals Inc. - From 12/21/23

Stock Information
Company Name: Lexicon Pharmaceuticals Inc.
Stock Symbol: LXRX
Market: NASDAQ
Website: lexpharma.com
Menu
LXRX LXRX Quote LXRX Short LXRX News LXRX Articles LXRX Message Board
Get LXRX Alerts

News, Short Squeeze, Breakout and More Instantly...
Lexicon Pharmaceuticals To Participate In The 42nd Annual JPMorgan Healthcare Conference | Benzinga

THE WOODLANDS, Texas, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) today announced its participation in the 42n...
Lexicon Pharmaceuticals to Participate in the 35th Annual Piper Sandler Healthcare Conference and the 6th Annual Evercore ISI HealthCONx Conference | Benzinga

THE WOODLANDS, Texas, Nov. 22, 2023 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) today announced its participation in the fol...

Insiders Buying Blend Labs And 3 Other Stocks Under $2 | Benzinga

The Dow Jones closed higher by over 50 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the...

Lexicon Pharmaceuticals to Participate in the Jefferies London Healthcare Conference | Benzinga

THE WOODLANDS, Texas, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) today announced its participation in the Jef...
Why Plus Therapeutics Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket | Benzinga

Gainers Cellectis S.A. (NASDAQ: CLLS) shares surged 152% to $2.43 in pre-market trading. Cellectis reported strategic collaboration and investment ...

AMD, Yum China, Paycom Software And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session | Benzinga

U.S. stock futures traded lower this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session. ...

Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session | Benzinga

Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 146.2% to $6.97. Aegis Capital Corp. acted as exclusive placement agent on a $5.0 million pri...
Director of Lexicon Pharmaceuticals Makes $1.10M Buy | Benzinga

Raymond Debbane, Director at Lexicon Pharmaceuticals (NASDAQ:LXRX), reported a large insider buy on October 12, according to a new SEC filing. Wha...

Lexicon Pharmaceuticals And 3 Other Stocks Under $2 Insiders Are Buying | Benzinga

The Dow Jones closed lower by around 0.5% on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the c...

Data Demonstrating Financial Impact of INPEFA® (Sotagliflozin) to be Presented at the Academy of Managed Care Pharmacy (AMCP) Nexus 2023 National Meeting | Benzinga

Studies address cost-effectiveness and budget impact of INPEFA, an inhibitor of SGLT2 and SGLT1 INPEFA recently approved by FDA for treatment of ...
Previous 10 Next 10